GENTIAN DIAGNOSTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.8 NOK | -2.13% |
|
+0.55% | -11.33% |
Chart calendar Gentian Diagnostics
1c6.Ag6XXnrKVqT4SKMGkod8dyR0n6vFOurOTKi_Gdj4DT0.b0zPCBCQYd2PAfY0_8A3AWEr7_mdb72mfcD6eu3OIHVaffo0EvxhnLU4-g~912f4228d933af904c5adc8e65aaf8e4
Upcoming events on Gentian Diagnostics
Past events on Gentian Diagnostics
| 2024-03-15 | China Association of Clinical Laboratory Practice Expo |
| 2024-02-09 03:00 am | Q4 2023 Earnings Call |
| 2024-02-09 02:00 am | Q4 2023 Earnings Release |
| 2024-02-06 | European Hidradenitis Suppurativa Foundation Conference |
| 2023-10-26 04:00 am | Q3 2023 Earnings Call |
| 2023-10-26 02:00 am | Q3 2023 Earnings Release |
| 2023-08-24 04:00 am | Q2 2023 Earnings Call |
| 2023-08-24 02:00 am | Q2 2023 Earnings Release |
| 2023-05-31 12:00 am | ABGSC Life Science Summit |
| 2023-05-05 03:00 am | Q1 2023 Earnings Call |
| 2023-05-05 02:00 am | Q1 2023 Earnings Release |
| 2023-05-04 04:00 am | Annual General Meeting |
| 2023-03-20 | International Symposium on Intensive Care & Emergency Medicine |
| 2023-02-16 04:00 am | FY 2022 Earnings Call |
| 2023-02-16 02:00 am | FY 2022 Earnings Release |
| 2022-10-27 04:00 am | Q3 2022 Earnings Call |
| 2022-10-27 02:15 am | Q3 2022 Earnings Release |
| 2022-08-25 04:00 am | Interim 2022 Earnings Call |
| 2022-08-25 02:00 am | Interim 2022 Earnings Release |
| 2022-05-17 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 55,4 | 78,9 78,5 0.45% | 101 104 -2.64% | 112 112 0.33% | 142 142 0.33% | 171 |
|
EBITDA Million NOK | Released Forecast Spread | 0,00 | -11,2 -8,63 -29.79% | -7,60 -6,00 -26.67% | -13,0 -14,2 8.66% | 3,27 4,56 -28.24% | 1,71 |
|
EBIT Million NOK | Released Forecast Spread | 0,00 | -17,8 -14,9 -19.79% | -14,9 -14,0 -6.47% | -23,2 -24,2 3.96% | -12,8 -5,74 -122.15% | -11,3 |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | 0,00 | -17,5 -14,0 -24.93% | -24,8 -17,0 -45.66% | -23,6 -24,3 2.62% | -10,4 -3,46 -199.13% | -11,5 |
|
Net income Million NOK | Released Forecast Spread | -39,9 | -17,5 -14,0 -24.93% | -24,8 -17,0 -45.66% | -23,6 -24,3 2.62% | -10,4 -3,46 -199.13% | -11,5 |
|
EPS NOK | Released Forecast Spread | 0,00 | -1,13 -0,91 -24.48% | -1,61 -1,10 -45.96% | -1,53 -1,57 2.71% | -0,69 -0,22 -207.35% | -0,75 |
| Announcement Date | 14/02/20 | 11/02/21 | 17/02/22 | 16/02/23 | 09/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million NOK | Released Forecast Spread | 26,2 29,0 -9.68% | 23,1 24,5 -5.84% | 32,9 30,0 9.48% | 25,1 24,4 2.74% | 30,9 30,5 1.19% | 33,6 29,4 14.42% |
|
EBITDA Million NOK | Released Forecast Spread | -0,60 1,00 -160% | -4,18 -0,65 -547.18% | -1,24 3,88 -131.94% | -6,06 -3,13 -93.82% | -1,50 -2,73 45% | -0,52 -9,32 94.46% |
|
EBIT Million NOK | Released Forecast Spread | -1,58 -1,00 -58.3% | -6,25 -2,44 -155.97% | -3,98 2,09 -290.87% | -8,74 -5,04 -73.33% | -4,27 -5,23 18.27% | -2,88 -7,51 61.74% |
|
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -9,55 -2,00 -377.25% | -6,63 -3,13 -111.55% | -2,99 1,49 -300.91% | -9,38 -5,66 -65.82% | -4,63 -5,26 12.04% | -0,66 -7,56 91.31% |
|
Net income Million NOK | Released Forecast Spread | -9,55 -2,00 -377.25% | -6,63 -3,13 -111.55% | -2,99 1,49 -300.91% | -9,38 -5,66 -65.82% | -4,63 -5,26 12.04% | -0,66 -7,56 91.31% |
|
EPS NOK | Released Forecast Spread | -0,62 -0,12 -415.83% | -0,43 -0,20 -111.62% | -0,19 0,10 -296.77% | -0,61 -0,37 -66.24% | ||
| Announcement Date | 17/02/22 | 28/04/22 | 25/08/22 | 27/10/22 | 16/02/23 | 05/05/23 |
More events
Past sector events for Gentian Diagnostics
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GENT Stock
- Calendar Gentian Diagnostics
